T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 22, 2016
app pub date -
Oct 1, 2014
filing date -
Oct 1, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A vaccine contains a long-chain peptide antigen having a plurality of epitopes. An interepitope sequence located between two of the plurality of epitopes contains two to ten consecutive tyrosines, two to ten consecutive threonines, two to ten consecutive alanines, two to ten consecutive histidines, two to ten consecutive glutamines or two to ten consecutive asparagines. The vaccine may be an anticancer vaccine, an antibacterial vaccine or an antiviral vaccine. The vaccine may be a peptide vaccine, a DNA vaccine, an mRNA vaccine or a dendritic cell vaccine.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully